Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) - Contacts and Locations

Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

This study is currently recruiting participants.

Study NCT00557622. Last updated on October 15, 2008. Information provided by GlaxoSmithKline

Please refer to this study by its ClinicalTrials.gov identifier: NCT00557622

Contacts


Contact: US GSK Clinical Trials Call Center	877-379-3718

Locations


Japan
	GSK Investigational Site	Active, not recruiting
	Tokyo, Japan, 170-0002
	GSK Investigational Site	Withdrawn
	Hiroshima, Japan, 734-8551
	GSK Investigational Site	Recruiting
	Tokyo, Japan, 113-8602
	GSK Investigational Site	Withdrawn
	Tokyo, Japan, 156-8585
	GSK Investigational Site	Withdrawn
	Tokyo, Japan, 113-8603
	GSK Investigational Site	Recruiting
	Tokyo, Japan, 114-0002
	GSK Investigational Site	Withdrawn
	Tokyo, Japan, 190-0014
	GSK Investigational Site	Active, not recruiting
	Tokyo, Japan, 162-0056
	GSK Investigational Site	Active, not recruiting
	Tokyo, Japan, 162-8666
	GSK Investigational Site	Withdrawn
	Tokyo, Japan, 187-8553
	GSK Investigational Site	Withdrawn
	Tokyo, Japan, 143-8541
	GSK Investigational Site	Recruiting
	Chiba, Japan, 272-0133

Sponsors and Collaborators

GlaxoSmithKline

Investigators


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline